MorphoSys AG — M&A Activity 2002

Oct 23, 2002

News Details

Ad-hoc | 23 October 2002 07:29

MorphoSys AG english

MorphoSys Updates Guidance Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– MorphoSys AG (Neuer Markt: MOR), the Munich-based biotechnology company, today announced that it has terminated merger talks with British Biotech plc (LSE: BBG, NASDAQ: BBYIO). MorphoSys also updated its guidance regarding strategic equity-based partnerships. The Company advised that it does not expect such a transaction to be completed in the current calendar year, and revised its expected year-end cash position down to approx. EUR 15 million. end of ad-hoc-announcement (c)DGAP 23.10.2002 ——————————————————————————– WKN: 663200; ISIN: DE0006632003; Index: Nemax 50 Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 230729 Okt 02